Compounders Research Compare

IM Cannabis Corp.(IMCC)

Drug Manufacturers - Specialty & Generic · Vancouver, BC

$1.90-0.04 (-2.06%)

Delayed quote: Oct 6, 2026, 12:55 PM EDT

About IM Cannabis Corp.

IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Vancouver, BC

44 employees

www.imcannabis.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Oren Shuster

View full financials

IM Cannabis (IMCC) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T16:57:10.002Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:57:10.002Z.

Quote observation: 2026-10-06T16:55:13.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: N/A
Quote price: 1.9

FMP input reference: 84f755396c9cc6b6c9535f897ba0f48fef5a33e79b5fb4c136097311f2feddf3

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

IMCC Earnings Yield Metrics

EARNINGS YIELD

N/A

IMCC Competitors' Earnings Yield

IM Cannabis Corp.

Current

Market Cap

$1.15M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Propanc Biopharma, Inc.

Market Cap

$1.14M

Earnings Yield

N/A

TTM Avg

3793.47%

3Y Avg

3793.47%

5Y Avg

3793.47%

Cellyan Biotechnology Co., Ltd

Market Cap

$1.10M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Clearmind Medicine Inc.

Market Cap

$1.07M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Jupiter Neurosciences, Inc.

Market Cap

$1.25M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aspire Biopharma Holdings, Inc.

Market Cap

$1.03M

Earnings Yield

N/A

TTM Avg

0.00%

3Y Avg

0.00%

5Y Avg

0.00%

NewcelX Ltd.

Market Cap

$1.32M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Genprex, Inc.

Market Cap

$1.34M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Artelo Biosciences, Inc.

Market Cap

$1.38M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GlucoTrack, Inc.

Market Cap

$881948.00

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
IM Cannabis Corp. (IMCC)	$1.15M	N/A	N/A	N/A	N/A
Propanc Biopharma, Inc. (PPCB)vs ›	$1.14M	N/A	3793.47%	3793.47%	3793.47%
Cellyan Biotechnology Co., Ltd (HKPD)vs ›	$1.10M	N/A	N/A	N/A	N/A
Clearmind Medicine Inc. (CMND)vs ›	$1.07M	N/A	N/A	N/A	N/A
Jupiter Neurosciences, Inc. (JUNS)vs ›	$1.25M	N/A	N/A	N/A	N/A
Aspire Biopharma Holdings, Inc. (ASBP)vs ›	$1.03M	N/A	0.00%	0.00%	0.00%
NewcelX Ltd. (NCEL)vs ›	$1.32M	N/A	N/A	N/A	N/A
Genprex, Inc. (GNPX)vs ›	$1.34M	N/A	N/A	N/A	N/A
Artelo Biosciences, Inc. (ARTL)vs ›	$1.38M	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$881948.00	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics